https://www.selleckchem.com/pr....oducts/ginsenoside-r
Primary outcome eGFR ≥ 60 HR = 0.81, 95%CI, 0.65-0.99, and eGFR less then 60 HR = 1.20, 95%CI, 0.95-1.53; interactionp = 0.014. Cardiovascular death eGFR ≥ 60 HR = 0.61, 95%CI, 0.42-0.88, and eGFR less then 60 HR = 1.16, 95%CI, 0.82-1.65; interactionp = 0.013. Non-fatal MI eGFR ≥ 60 HR = 0.86, 95%CI, 0.66-1.13, and eGFR less then 60 HR = 1.48, 95%CI, 1.07-2.06; interactionp = 0.013. Conclusions Alogliptin may benefit patients with eGFR ≥ 60, but may be detrimental to patients with eGFR less then 60 ml/min/1.73m2. These hypothesi
Like
Comment
Share
